Information Materials
2024/2025 School Programme
In January 2024 school teams will deliver consent packs to your child's school. Your child will bring the consent pack home. Please read the information carefully and sign the consent form in the pack.
Each pack contains:
Information booklet English (1.065MB) | Irish (921kb) | Arabic (228KB) | Polish (234KB) | Romanian (228KB) | Russian (209KB) | Simplified Chinese (397KB) | Ukrainian (210KB)
Letter to parents and guardians English (152kb) | Irish (118kb)
Consent Form English (178kb) | Irish (180kb)
The pack also contains an envelope so you can send the completed consent form back to the school with your child before the school immunisation team visits.
After your child is vaccinated they will be given:
Post Vaccination Advice English (140kb) | Irish (142kb)
You can contact the school immunisation team if you have any questions
Poster English (5.1mb)
The vaccine used in the school programme in Ireland is called Gardasil9. It is manufactured by MSD. The licensed documents for each vaccines the Summary of Product Characteristics and the Patient Information Leaflet are available from the HPRA Website.
- Gardasil - Summary of Product Characteristics (SPC) and (you will be directed to the HPRA website)
- Gardasil - Patient Information Leaflet (PIL) for more information about the vaccine. (you will be directed to the HPRA website)
Information for HSE School Teams
- Royal College of Physicians of Ireland - Immunisation Guidelines for Ireland. Chapter 10 - Human Papillomavirus (you will be directed to the HIQA website)
- Supporting Information for Staff - School Immunisation Programme 2025/2026 academic year (1.05MB)
- HPV Frequently Asked Questions (480KB) (August 2024)
- Gardasil9 - Summary of Product Characteristics (SPC) (you will be directed to the HPRA website)
- Gardasil9 - Patient Information Leaflet (PIL) (you will be directed to the HPRA website)
Medicine Protocol for the School Immunisation Programme
- Gardasil 9 Medicine Protocol
- Anaphylaxis Protocol (updated February 2023)
- Change to the NIAC Guidelines for the treatment of Anaphylaxis